Corcept Therapeutics

About Corcept Therapeutics

Corcept Therapeutics is at the forefront of cortisol modulation, aiming to revolutionize the treatment of serious diseases. With 25 years of expertise, we lead in developing selective glucocorticoid receptor antagonists. Our FDA-approved treatment for hypercortisolism marked a milestone. We continue to innovate with over 500 GR antagonists for oncology, endocrine, and metabolic disorders. Join us in embracing possibility and transforming disease understanding.

Overview

• Website
• LinkedIn
• 201-500 employees
• Founded in 1998
• 14 active jobs
• Hiring in:
  • 🇺🇸 United States
• Updated Apr 19, 2025